CURRENT STATUS OF TAXOL (PACLITAXEL) RESEARCH

被引：0
|
作者：
SUFFNESS, M [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1994年 / 207卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：141 / MEDI
相关论文
共 50 条
  • [1] PACLITAXEL (TAXOL)
    KOHLER, DR
    GOLDSPIEL, BR
    PHARMACOTHERAPY, 1994, 14 (01): : 3 - 34
  • [2] CURRENT DOSAGE AND SCHEDULE ISSUES IN THE DEVELOPMENT OF PACLITAXEL (TAXOL(R))
    ARBUCK, SG
    CANETTA, R
    ONETTO, N
    CHRISTIAN, MC
    SEMINARS IN ONCOLOGY, 1993, 20 (04) : 31 - 39
  • [3] TAXOL AND TAXOTERE - CURRENT STATUS AND FUTURE-PROSPECTS
    BISSETT, D
    KAYE, SB
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) : 1228 - 1231
  • [4] EXTRAVASATION OF PACLITAXEL (TAXOL(R))
    RAYMOND, E
    CARTIER, S
    CANUEL, C
    LOUVET, C
    DEMUYNCK, B
    DEBRAY, M
    VARETTE, C
    BAUX, S
    MIMOUN, M
    DEGRAMONT, A
    KRULIK, M
    REVUE DE MEDECINE INTERNE, 1995, 16 (02): : 141 - 142
  • [5] HISTORY, DEVELOPMENT, AND CURRENT STATUS OF TAXOL AT THE NATIONAL CANCER INSTITUTE
    SUFFNESS, M
    SNADER, KM
    CRAGG, GM
    SCHEPARTZ, SA
    GREVER, MR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 191 - MEDI
  • [6] Cytotoxicity of fractionated paclitaxel (Taxol®) administration in vitroZytotoxizität fraktionierter Paclitaxel-(Taxol®-)Gabe in vitro
    L. Plasswilm
    N. Cordes
    R. Fietkau
    R. Sauer
    Strahlentherapie und Onkologie, 1998, 174 : 37 - 42
  • [7] Extravasation of paclitaxel (TAXOL®) -: Clinical course
    Riedel, U
    Serke, M
    Schönfeld, N
    Loddenkemper, R
    ONKOLOGIE, 1999, 22 (04): : 318 - 320
  • [8] Cardiac effects of taxol (paclitaxel) and analogues
    Alloatti, G
    Penna, C
    Gallo, MP
    Levi, RC
    Bombardelli, E
    Appendino, G
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 434 (02): : 1 - 1
  • [9] Paclitaxel (Taxol(R)) for the treatment of lymphoma
    Younes, A
    Ayoub, JP
    Sarris, A
    North, L
    Pate, O
    McLaughlin, P
    Rodriguez, MA
    Romaguera, J
    Hagemeister, F
    Bachier, C
    Preti, A
    Cabanillas, F
    ANNALS OF ONCOLOGY, 1997, 8 : 129 - 131
  • [10] AN OVERVIEW OF EXPERIENCE WITH TAXOL (PACLITAXEL) IN THE USA
    DONEHOWER, RC
    ROWINSKY, EK
    CANCER TREATMENT REVIEWS, 1993, 19 : 63 - 78
12345